National and Kapodistrian University of Athens
Αγγειογενετικές και ανοσολογικές παραμέτροι στον ιστό μη μικροκυτταρικού καρκίνου του πνεύμονα πριν και μετά τη θεραπεία
Abstract
dc:descriptionPurpose The expression of various angiogenic factors was assessed in tumour samplesof patients with stage III NSCLC before treatment and further analyzed in relation toresponse to Paclitaxel-Ifosfamide-Cisplatin (TIP) chemotherapy.Methods Freshly isolated lung tumour specimens from 35 NSCLC chemotherapy naïvepatients were sampled and analysed for vascular endothelial growth factor receptor-1(VEGFR-1), VEGFR-2 and VEGFR-3, Tumor necrosis factor-alpha (TNFa), Tumorgrowth factor-beta (TGFb), interleukin-6 (IL6) and IL8, before and after treatment.Immunostaining scores were calculated by multiplying the percentage of labeled cellsby the intensity of staining for each examined parameter.Results The overall expression of VEGF receptors and particularly of VEGFR1 wasdecreased in 68.6% of patients, increased in 22.9% and remained stable in 8.6% afterthe completion of treatment. Similar results were found for VEGFR3 (68.6% decreased,25.7% increased and 5.7% stable). For VEGFR2 there was an important increase of thevalue in 65.7% of patients (p<0.01), as the decrease and stable values were foundsimilar (17%). There were no statistically important differences for all immunologicparameters before and after treatment: TNFa (increase 54.3%, decrease 34.3%, stable20%, p-0.28) TGFb (increase 48.6%, decrease 34.3%, stable 17.1%, p-0.13), but nostatistically important differences for IL6 (increase 34.3%, decrease 28.6%, stable37.1%, p-0.78) and IL8 (increase 26.5%, decrease 32.4% and stable 41.2%, p-0.84).Conclusion Our study identified patterns of angiogenic marker expression withpredictive significance in stage III NSCLC treated with TIP chemotherapy. Thedecrease of VEGFR1 and VEGFR3 after treatment it is probably related to the decreaseof the tumour size, as the increase of VEGFR2 values could be related to high levels ofprecancerous growth factors including VEGF that are released in the circulation afterchemotherapy something that requires futher investigation.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koufos, Nikolaos
- Κουφός, Νικόλαος
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35956